CJ BIO announced Aug. 18 that its new L-threonine product, THR Pro, has completed Food & Drug Administration evaluation with a letter of agreement from the company that THR Pro is a safe source of threonine for livestock and poultry.
CJ BIO noted that THR Pro is an 80% active granular source of L-threonine, with residual biomass. The product is manufactured at the company's Ft. Dodge, Iowa, facility along with the amino acids lysine and arginine. All customers in the U.S. will now be able to access another source of domestically produced threonine, the company said.
“We are gratified with this outcome, an important milestone in our expansion of CJ’s United States manufacturing base. It is a logical extension of our domestically produced portfolio,” said Joe Lucas, CJ America vice president and general manager-animal nutrition. “We will now launch THR Pro for all U.S. customers in all states. Previously, we had marketed the product only in states with a specific state waiver, and that early launch far exceeded our expectations. As a result, we will consider increasing threonine capacity in the coming months.”
“We are committed to continue working to meet our customers’ needs and grow our amino acid portfolio using cost-competitive local production,” added Harry Jang, head of CJ BIO for North and South America.
CJ BIO is a division of CJ CheilJedang, a core subsidiary in charge of the food and bioengineering business unit of the CJ Group.